|
GGTLC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.49239997716234E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39010000177464E-08 |
| Normal-vs-Stage2 |
1.602430E-02 |
| Normal-vs-Stage3 |
1.762380E-01 |
| Normal-vs-Stage4 |
4.027400E-01 |
| Stage1-vs-Stage2 |
9.698200E-01 |
| Stage1-vs-Stage3 |
5.240900E-03 |
| Stage1-vs-Stage4 |
1.297920E-02 |
| Stage2-vs-Stage3 |
1.062420E-01 |
| Stage2-vs-Stage4 |
8.159600E-02 |
| Stage3-vs-Stage4 |
7.548000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10690000498792E-08 |
| Normal-vs-AfricanAmerican |
9.80569999999847E-05 |
| Normal-vs-Asian |
2.849000E-01 |
| Caucasian-vs-AfricanAmerican |
6.346000E-01 |
| Caucasian-vs-Asian |
3.391000E-01 |
| AfricanAmerican-vs-Asian |
3.459000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.03399999463028E-09 |
| Normal-vs-Female |
1.324480E-03 |
| Male-vs-Female |
4.269600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.442600E-04 |
| Normal-vs-Extreme_Weight |
1.97212999999419E-05 |
| Normal-vs-Obese |
3.033400E-04 |
| Normal-vs-Extreme_Obese |
2.843600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.674400E-01 |
| Normal_Weight-vs-Obese |
5.317200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.377400E-01 |
| Extreme_Weight-vs-Obese |
9.858800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.592780E-01 |
| Obese-vs-Extreme_Obese |
1.620560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.546000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.72009999999112E-06 |
| Normal-vs-Age(61-80Yrs) |
7.54250000234435E-08 |
| Normal-vs-Age(81-100Yrs) |
2.116200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.865600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.005200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.852200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.047200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.882400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.261600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.03801469828613E-13 |
| Normal-VS-Type2 PRCC |
2.341200E-03 |
| Normal-VS-KIRP CIMP |
2.07070000002307E-06 |
| Normal-VS-Unclassified PRCC |
1.194180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.370500E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.62436730732907E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
2.257400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.00709457334847E-11 |
| Type2 PRCC-VS-Unclassified PRCC |
5.020600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.69040000000243E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.229680E-04 |
| Normal-vs-N1 |
5.250800E-01 |
| Normal-vs-N2 |
4.657000E-01 |
| N0-vs-N1 |
1.883430E-03 |
| N0-vs-N2 |
5.024600E-01 |
| N1-vs-N2 |
4.474400E-01 |
|
|
